Ross, Jason B. http://orcid.org/0000-0002-0816-1314
Myers, Lara M.
Noh, Joseph J.
Collins, Madison M.
Carmody, Aaron B.
Messer, Ronald J.
Dhuey, Erica http://orcid.org/0000-0002-5961-0722
Hasenkrug, Kim J. http://orcid.org/0000-0001-8523-4911
Weissman, Irving L. http://orcid.org/0000-0002-9077-7467
Article History
Received: 26 October 2022
Accepted: 26 February 2024
First Online: 27 March 2024
Competing interests
: I.L.W. is listed as an inventor on patents related to CD47 licensed to Gilead Sciences, but has no financial interests in Gilead; he is also a co-founder and equity holder of Bitterroot Bio, PHeast and 48 Bio; he is on the scientific advisory board of Appia. J.B.R. is a co-founder and equity holder of 48 Bio. I.L.W., K.J.H., J.B.R., L.M.M. and J.N.N. are listed as co-inventors on a pending patent application related to this work. The other authors declare no competing interests.